Welcome to our dedicated page for Avant Brands news (Ticker: AVTBF), a resource for investors and traders seeking the latest updates and insights on Avant Brands stock.
Avant Brands Inc (AVTBF) is a globally recognized producer of premium craft cannabis, operating state-of-the-art facilities with ICANN-GAP and GACP certifications. This news hub provides investors, analysts, and industry professionals with centralized access to official announcements and strategic developments shaping the company's position in recreational, medical, and international cannabis markets.
Track critical updates including quarterly earnings reports, international licensing agreements, product innovations, and regulatory compliance milestones. Our curated collection ensures timely access to press releases detailing expansion initiatives, partnership announcements, and operational achievements across Avant Brands' diversified business segments.
Key focus areas include cultivation advancements, market entry strategies in regions like Europe and Australia, and quality control enhancements. This resource serves as an essential tool for monitoring the company's progress in executing its vertically integrated business model while maintaining premium product standards.
Bookmark this page for streamlined access to verified information directly impacting Avant Brands' market performance and long-term growth trajectory. Regularly updated content supports informed decision-making for stakeholders tracking the evolving cannabis sector.
Avant Brands (OTCQX:AVTBF) reported Q3 2025 results for the quarter ended August 31, 2025, showing continued operational improvement and positive cash generation.
Key metrics: quarterly gross revenue $10.8M (+13%), net revenue $9.4M (+11%), YTD gross profit $3.1M (+3851%), adjusted EBITDA $0.2M (eighth consecutive positive quarter), and YTD operating cash flows $3.7M (+111%). Domestic wholesale revenue rose sharply (+307%) while export wholesale fell (-16%), producing a combined wholesale total of $6.5M (+17% vs Q3 2024).
Avant Brands (OTCQX:AVTBF) has been named one of Canada's Top Growing Companies by The Globe and Mail for the third consecutive year. The company ranked 138th on the 2025 list with impressive three-year revenue growth of 263%, following its previous rankings of #49 in 2023 and #182 in 2024.
The recognition, part of The Globe and Mail's Report on Business ranking system launched in 2019, celebrates innovative Canadian businesses that meet specific revenue growth criteria. Avant, known for producing innovative and award-winning cannabis products, aims to leverage this momentum for global expansion and strengthen its position in premium markets.
Avant Brands (OTCQX:AVTBF) released its Q2 2025 financial results, marking its sixth consecutive quarter of positive Adjusted EBITDA at $1.2 million. The company reported gross revenue of $9.7 million (+3% YoY) and net revenue of $8.5 million (+3% YoY).
Export wholesale revenue grew 11% to $4.1 million, driven by strong international demand in Germany, Israel, and Australia. Domestic wholesale revenue increased 37% to $1.3 million, while recreational revenue declined 14% to $2.9 million due to strategic SKU optimization. The company's cannabis production reached 3,327 KG (+4%), with sales volume of 2,799 KG (+3%).
However, gross margin adjusted for fair value adjustments decreased to 26% from 37% in Q2 2024, while YTD net cash flows from operations improved by 7% to $2.6 million.
Avant Brands (TSX:AVNT, OTCQX:AVTBF) has announced its annual general and special meeting scheduled for May 30, 2025, at 1:00 p.m. PDT in Kelowna, BC. Key highlights include proposed amendments to previously issued convertible securities:
The company has entered into Repricing Amendments on April 21, 2025, affecting:
- Warrants: Exercise price reduction from $3.00 to $1.75
- Convertible Debentures: Staged conversion price reductions from $3.00 to:
- $1.25 (first 3 months post-approval)
- $1.50 (3-6 months post-approval)
- $1.75 (6 months to maturity)
These amendments remain subject to TSX and shareholder approval. Shareholders of record as of April 14, 2025, will be eligible to vote at the meeting. Meeting materials will be available on the company's website and SEDAR+.
Avant Brands (AVTBF) has reported its Q1 2025 financial results, showing notable growth in several key metrics. Gross Revenue increased 8% to $9.7 million, while Net Revenue rose 7% to $8.6 million compared to Q1 2024.
The company's Export Wholesale Revenue saw significant growth, reaching $4.7 million (+41%), driven by strong demand in Australia, Germany, and Israel. However, Recreational Revenue declined 16% to $2.8 million, and Domestic Wholesale Revenue decreased 28% to $0.9 million following a strategic SKU realignment.
Financial highlights include a Gross Profit increase to $1.6 million (from $0.9 million), marking the fifth consecutive quarter of positive Adjusted EBITDA ($1.7 million) and Adjusted Net Income ($0.5 million). Cannabis production reached 3,326 KG (+3%), with sales volume up 21% to 3,360 KG. The Gross Margin percentage adjusted for fair value adjustments decreased to 34% from 58% due to market price compression and increased cultivation costs.
Avant Brands reported record financial results for fiscal year 2024, with gross revenue reaching $40.0 million (+32% YoY) and net revenue of $35.8 million (+36% YoY). The company achieved significant growth in export wholesale revenue, reaching $19.4 million (+107% YoY), driven by strong international demand from Australia, Germany, and Israel.
Q4 2024 highlights include record gross revenue of $12.1 million (+109% YoY) and net revenue of $11.0 million (+127% YoY). However, the company reported a gross loss of $1.8 million in Q4 2024, compared to a $1.0 million profit in Q4 2023, primarily due to biological asset valuations.
Cannabis production increased 19% to 12,643 kg in FY 2024, while sales volume grew 91% to 13,560 kg. The company maintained positive Adjusted EBITDA and Adjusted Net Income for four consecutive quarters, with Q4 2024 achieving $2.3 million and $2.7 million respectively.
Avant Brands (TSX:AVNT) (OTCQX:AVTBF) reported record financial results for Q3 2024, ending August 31, 2024. Highlights include:
- Record gross revenue of $9.6 million (+27% YoY)
- Record net revenue of $8.5 million (+30% YoY)
- Record export wholesale revenue of $5.1 million (+116% YoY)
- Record cannabis production of 3,441 kg (+5% YoY)
- Record cannabis sales of 3,087 kg (+98% YoY)
The company's growth was driven by strong international demand, particularly in Australia, Germany, and Israel. Avant achieved an Adjusted EBITDA of $2.1 million and Adjusted Net Income of $0.5 million. The company's cash balance increased by $2.4 million year-to-date. Avant continues to expand its global footprint, executing nine international agreements and shipping products to four new clients.
Avant Brands Inc. has entered an exclusive trademark licensing agreement with Nectar Portfolio Pty to introduce its BLK MKT™ brand to the Australian medical cannabis market. This expands Avant's global footprint, with BLK MKT™ now available in Canada, Australia, Germany, Israel, and Switzerland, reaching a combined population of about 127 million.
Key highlights include:
- Nectar's exclusive rights to market, sell, and distribute BLK MKT™ dried cannabis flower in Australia for two years
- Products will be cultivated by Avant in Canada, meeting Australian medicinal cannabis standards
- Avant will receive its standard international sales price plus a royalty fee on Nectar's net sales
This partnership is expected to generate incremental revenue growth for Avant Brands and establish BLK MKT™ as a leading global cannabis brand.
FAQ
What is the current stock price of Avant Brands (AVTBF)?
What is the market cap of Avant Brands (AVTBF)?
